This is particularly problematic for the post-PEA and distal de novo inoperable CTEPH sub-groups, which were also not well matched for either functional level as measured by quality-of-life scores, 6MWT, NT pro-BNP and hemodynamic variables. The gene discussed is NPPB; the disease is chronic thromboembolic pulmonary hypertension.